Research has indicated that the SH3 domain of the ABL1 protein negatively regulates its function, and high expression of ABL1 often indicates poor prognosis, which is commonly observed in chronic myeloid leukemia, but it is less studied in other cancers [42]. The gene discussed is ABL1; the disease is cancer.